// App-Quantinova.ai

2516 : Pediatric Acute Myeloid Leukemia with t(8;16)(p11;p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin-Frankfurt-Munster AML Study Group.

Researchers

Presenter

  • C. Michel Zwaan

Principal Investigators

  • Todd A. Alonzo

  • Henrik Hasle

  • Dirk Reinhardt

  • Anne Auvrignon

  • Michael Dworzak

  • Andrea Pession

  • Vincent H.J. van der Velden

  • John Swansbury

  • Kit Fai Wong

  • Oskar A. Haas

  • Kiminori Terui

  • Sureyya Savasan

  • M Winstanley

  • G Vaitkeviciene

  • Martin Zimmermann

  • Rob Pieters

  • Marry M. van den Heuvel-Eibrink

  • Valerie de Haas

  • V Mihal

  • Barbara De Moerloose

  • M Jeison

  • Jeffrey Rubnitz

  • Daisuke Tomizawa

  • Donna Johnston

Medical Centers

  • Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

  • Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands

  • Department of Radiation Oncology, Ghent University Hospital, Gent, Belgium

  • Department of Pediatrics, Aarhus University Hospital, Skejby, Aarhus, Denmark

  • Japanese Pediatric Leukemia/Lymphoma Study Group, Nagoya, Japan

  • St. Anna Children s Hospital, Vienna, Austria

  • St. Anna Children's Hospital and Department of Paediatrics, Medical University, Vienna, Austria

  • The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

  • Sutton, United Kingdom

  • Northern Institute For Cancer Research, Newcastle upon Tyne, United Kingdom.

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Cancer Cytogenetic Laboratory, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Department of Pediatric Oncology, Starship Children's Hospital, Auckland, New Zealand

  • AML-BFM Study Group, Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany

  • Department of Clinical Cytogenetics, The Royal Marsden Hospital & Department of pediatric oncology, Vilnius University Hospital, Vilnius, Lithuania,

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • ANLL study group of AIEOP, Bologna, Italy

  • Department of Pediatrics, Czech Pediatric Hematology/Oncology, Olomouc, Czech Republic

  • Pathology, Queen Elizabeth Hospital, Hong kong, China

  • Dutch Childhood Oncology Group, The Hague, Netherlands.

  • AML BFM study group, Hannover Medical School, Hannover, Germany

  • French LAME Leucemie Aigue Myeloblastique Enfant Cooperative Group, France

Locations

  • Canada

  • Czech Republic

  • Japan

  • Italy

  • Austria

  • China

  • Netherlands

  • Germany

  • United Kingdom

  • Lithuania

  • Israel

  • France

  • Denmark

  • Belgium

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Disseminated intravascular coagulation

  • Acute myelocytic leukemia

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • p53

  • P53 Apoptosis Effector Related To PMP-22

  • Ret Proto-Oncogene

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved